GERARDO CABRERA CONTRERAS: Open Payments
NPI 1972239176 · WALNUT HILLS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,150 in 41 payments from 10 companies in 2025. Trend: 2023 $2,497 · 2024 $2,367 · 2025 $1,150
Food & beverage: $1,146Education: $4
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $286 |
| Otsuka America Pharmaceutical, Inc. | 3 | $257 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $192 |
| Neurocrine BioSciences, Inc. | 6 | $154 |
| Teva Pharmaceuticals USA, Inc. | 5 | $123 |
| Janssen Pharmaceuticals, Inc | 4 | $61 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, ABILIFY MAINTENA, REXULTI, AUSTEDO XR, INVEGA SUSTENNA, UZEDY.
Industry payments across OH — which companies pay providers there.
